AGC Biologics
AGC Biologics Buys 300KSF Boulder Plant
The global pharmaceutical company will invest $100 million to transform the Colorado facility, which had been owned and occupied by AstraZeneca.
The global pharmaceutical company will invest $100 million to transform the Colorado facility, which had been owned and occupied by AstraZeneca.